Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Determination of cyclin-dependent kinase inhibitor P27 levels as a prognostic factor in cancer patients

Determination of cyclin-dependent kinase inhibitor P27 levels as a prognostic factor in cancer patients

US Patent 6180333 · Granted Jan 30, 2001

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System basis chip having selectable power sequence configurations, corresponding2024
Timing system including a master device and at least a slave device synchronized2023
Overcurrent detection circuit, corresponding system and method2023
Call forwarding detection in voice over packet interception2020
Methods of diagnosing, prognosing and treating breast cancer2009
Peptide inhibitors of cyclin-dependent kinase activity and uses thereof2008
Human cyclin-dependent kinase-like proteins and methods of using the same2004
Method of inhibiting cancer cell growth using a vector expressing pRb2/P1302003
Methods of inhibiting smooth muscle cell proliferation and preventing restenosis2003
prb2/p130 peptide inhibitors of cdk2 kinase activity2001
Human cyclin-dependent kinase-like proteins and methods of using the same2000
Methods for the diagnosis and prognosis of cancer1998